Obesity defined as a disease. Advances in artificial pancreas design to reduce complications in Type 1 diabetes. New developments with insulin delivery. The latest app for helping diabetics manage their condition. These are a just a few of the likely talking points at the 73rd Scientific Sessions for the American Diabetes Association (#2013ADA) underway in Chicago. If you want to follow the social media chatter around the event and beyond from several perspectives from an e-patient to a healthcare professional, to a drug developer and investor, here are nine people to follow on Twitter.
Dennis Urbaniak (@DUbaniak) is the vice president of diabetes at Sanofi-Aventis.
Christopher Snider (@iam_Spartacus) writes about his Type 1 Diabetes on his blog A Consequence of Hypoglycemia and is working at the #2013ADA conference.
Kerri Morrone Sparling (@sixuntilme) is a writer and social media consultant who authors the blog sixuntilme that charts Sparling’s experiences living with Type 1 diabetes.
Bea Dominguez (@crankypancreas) authors the blog Cranky Pancreas about Dominguez’s life with Type 2 diabetes.
John Brooks III (@JoslinCEO) is the CEO of Joslin Diabetes Center.
Ryan Luce (@Corengi) is the primary founder of Corengi, a website that helps type 2 diabetes patients find clinical trials that are right for them
Jane Speight (@janespeight) is the foundation director for the Australian Centre for Behavioural Research in Diabetes in Melbourne.
Barbianne Davis (@Rnmama1) is a nurse at Heritage Valley Sewickley hospital.
John E. Milad (@jemilad) is a #medtech and #digitalhealth venture capitalist. He is an investment director at NBGI Ventures.
[Photo credit: Social media from BigStock Photos]
Hear the latest industry news first
Get our daily newsletter or follow us.
Please enter your email below: